Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001193125-09-085748
Filing Date
2009-04-23
Accepted
2009-04-23 16:00:56
Documents
5
Period of Report
2008-12-31

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 1 TO FORM 10-K d10ka.htm 10-K/A 195405
2 CERTIFICATION OF CHIEF EXECUTIVE OFFICER dex311.htm EX-31.1 9908
3 CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER dex312.htm EX-31.2 9919
4 CERTIFICATION PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 dex321.htm EX-32.1 4066
5 CERTIFICATION PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 dex322.htm EX-32.2 4046
  Complete submission text file 0001193125-09-085748.txt   224857
Mailing Address 115 SANSOME STREET, SUITE 310 SAN FRANCISCO CA 94104
Business Address 115 SANSOME STREET, SUITE 310 SAN FRANCISCO CA 94104 (415) 875-7880
Nile Therapeutics, Inc. (Filer) CIK: 0001133869 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 001-34058 | Film No.: 09766643
SIC: 2834 Pharmaceutical Preparations